NOBIVAC FLEX TRICAT

البلد: أستراليا

اللغة: الإنجليزية

المصدر: APVMA (Australian Pesticides and Veterinary Medicines Authority)

العنصر النشط:

FELINE CALICIVIRUS - LIVE; LIVE FELINE HERPES VIRUS; FELINE PANLEUCOPENIA VIRUS - LIVE

متاح من:

INTERVET AUSTRALIA PTY LIMITED

INN (الاسم الدولي):

feline calicivirus+feline rhinotracheitis+vaccine - feline enteritis

الشكل الصيدلاني:

MISC. VACCINES OR ANTI SERA

تركيب:

FELINE CALICIVIRUS - LIVE VACCINE-VIRAL Active 4.6 PFU/dose; LIVE FELINE HERPES VIRUS VACCINE-VIRAL Active 5.2 PFU/dose; FELINE PANLEUCOPENIA VIRUS - LIVE VACCINE-VIRAL Active 4.3 TCI50/do

الوحدات في الحزمة:

*10; *20; *25; *50; *dose; *single; *vials

الفئة:

VM - Veterinary Medicine

المصنعة من قبل:

INTERVET AUSTRALIA

المجال العلاجي:

IMMUNOTHERAPY

ملخص المنتج:

Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: CAT: [FELINE CALICIVIRUS, FELINE ENTERITIS, FELINE RHINOTRACHEITIS]; Contains live feline calicivirus, live feline herpes virus type 1 and live feline panleucopaenia virus.The safety of these products has not been tested in pregnant or lactating queens. Live FPL virus can cause reproductive problems in pregnant cats and birth defects in the progeny. See also PRECAUTIONS and SIDE EFFECTS on label.

الوضع إذن:

Registered

تاريخ الترخيص:

2023-07-01

نشرة المعلومات

Product Name:
APVMA Approval Number:
NOBIVAC
FLEX
TRICAT
62996 / 128492
Label Name:
Nobivac Flex Tricat
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
Each single dose contains at least:
5.2 log^10 PFU
1
live feline herpes virus type 1 G2620A strain,
4.6 log^10 PFU of live feline calicivirus F9 strain and
4.3 log^10 CCID
50
2
live feline panleucopaenia virus MW-1 strain.
1
PFU: Plaque-Forming Units
2
CCID
50
: Cell Culture Infective Dose 50%
Claims:
For the active immunisation of cats to reduce the clinical signs
caused by infection
with feline calicivirus and feline herpes virus type 1
,
and prevention of clinical signs and
leucopaenia caused by feline panleucopaenia infection and a reduction
of virus excretion
following feline panleucopaenia infection.
Net Contents:
10 x single dose vials (1 mL after reconstitution)
20 x single dose vials (1 mL after reconstitution)
25 x single dose vials (1 mL after reconstitution)
50 x single dose vials (1 mL after reconstitution)
Directions for Use:
Restraints:
Contraindications:
Precautions:
The safety of these products has not been tested in pregnant or
lactating queens. Live
feline panleucop
a
enia virus (FPV) can cause reproductive problems in pregnant cats
and birth defects in the progeny. RLP APPROVED
Only healthy cats should be vaccinated and an adequate clinical
examination should be
made prior to inoculation. Sterile equipment should be used for
administration, but avoid
contamination of vaccine with traces of disinfectant or spirit.
Side Effects:
A slight, painful swelling may be observed at the injection site for
1-2 days. A slight
transient rise in body temperature (up to 40°C) may occur for 1-2
days. In some cases,
general discomfort, coughing, sneezing, transient lethargy and a
reduced appetite may
be observed for a few days post-vaccination. In very rare cases, the
vaccine may cause
hypersensitivity reactions (pruritus, dyspnoea, vomiting, diarrhoea
and collapse).
Dosage and
Administ